White pills close-up on a blue-white background. close-up, pharmacovigilance, safety quality control
The ever-growing volume of data from clinical trials, drug use and other sources presents both opportunities and challenges for pharmacovigilance. COVID-19 has presented an array of possibilities for pharmacovigilance service providers. Detecting and evaluating potential safety signals is essential to maintain the safety of drugs and other therapeutic products.
Companies are constantly challenged to keep costs down to optimize their investment, focus on patient safety and undertake benefit/risk analysis of products. The hard truth is that pharmacovigilance is an additional cost that doesn’t draw revenue but is an essential requirement to do business. The pharmaceutical industry has learned that pharmacovigilance is more than a business necessity. Pharmacovigilance can be an asset as it can inform discov…